Composition
- Active ingredients
- DIDANOSINE 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DIDANOSINE 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, delayed rel pelletsNDA021183-003 · Discontinued
- DIDANOSINE 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, delayed rel pelletsThis page
- DIDANOSINE 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, delayed rel pelletsNDA021183-004 · Discontinued
- DIDANOSINE 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, delayed rel pelletsNDA021183-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021183.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Videx EC
- Active substance
- didanosine
- Route
- Oral
- Dosage form
- Capsule, delayed rel pellets
- Applicant
- Bristol Myers Squibb
- Status
- Discontinued
- FDA approval
- 31 Oct 2000
- Application
- NDA021183-001